Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Healthcare Biotechnology

Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01, its lead clinical-stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. ACP-01 is in a Phase 2 clinical trial in Canada and the United States. Its technology includes methods for collecting the synergetic cell population and manufacturing a personalized regenerative therapy that can be administered to a patient within seven days of the initial cell collection. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd. and PreCerv Inc.

TSXV:HEM - Post by User

Hemostemix Inc > IS THE DAWN OF THE STEM CELL REVOLUTION FINALLY HERE?

<< Previous

Bullboard Posts

Next >>

Post by Pimpovishon Dec 27, 2020 8:32pm

370 Views

Post# 32186147

IS THE DAWN OF THE STEM CELL REVOLUTION FINALLY HERE?

Unlike the crypto, psychedelics or cannabis space, this stock is grounded in a pharma segment with less volatility and more sequential value escalation. The most impressive aspect of this company is the IP. 10 years of data and 91 patents in the autologous stem cell niche gives them leadership status. I dont want to sound presumptuous and say this stock is going to do a near term triple and by no means will it stop there.
However, I'm going to go out on a limb and be presumptuous. I think investors are starting to wake up to the realization that a previous negative scenario has done a front roll into a very positive outcome. Lucky were the buyers that bought 1-2 cents. They had Nostradamus like foresight. The reality is the stock still remains severely undervalued and consequently is still a screaming buy. I fully expect to see a frenzy of buying pressure pre-rollback. My call is 4-5 cents. This is an unusual rollback as it is being done on strength. The IP's value will soon be magnified with midpoint statistical results. I can transparently say big buying is coming into this stock. Frankly, its already started. A couple of whales have come in and they are now communicating with their respective networks. Look for a rising share price and attention grabbing volume over the next 2 trading sessions. Anyone that wants to wait post rollback to buy is either going to be very smart or very wrong. The 20:1 consolidation is going to make it difficult to amass size. Further, it would be logical to think the company has plans to bring in IR and PR to generate awareness. They will be well funded to do so. Another wildcard to consider is the possibility of a large Pharma partner coming to the table. Another wildcard possibility is the potential buyout of the company once they obtain their midpoint results. There is massive risk/reward with Hemostemix. Maybe the best I've seen in years. These are all expressed opinions but as a large investor, I'm loving my odds on a big ROI.